ELRIG, a not-for-profit, volunteer-led organisation dedicated to the global drug discovery community, today announced the ...

Researchers developed a DNA barcoding assay to measure nanoparticle cargo escape in living organisms, enabling a new class of lipid nanoparticles for more efficient gene editing.

In this GEN Learning Lab, our expert panelists Linda Orzolek, MS, MB, Xuhuai Ji, MD, PhD, and Christina Chang, PhD, will discuss the current landscape of imaging- and next-generation sequencing-based ...

Dr. Markus Gershater explains how High Dimensional Experimentation (HDE) revolutionizes assay development by replacing one-factor-at-a-time (OFAT) methods with automated, multivariate workflows.

Non-CHO cell expression systems gain traction as faster, more flexible alternatives for biologics manufacturing.

Nina Bauer of FUJIFILM Cellular Dynamics shares insight on addressing challenges and supporting developers heading towards commercialization.

A team led by Professor Inkyung Jung from the Department of Biological Sciences at KAIST, working with Professor Yarui Diao’s ...

Provisional license allows Rapid Novor to begin testing Canadian patients using a highly sensitive, non-invasive blood-based assay for measurable residual disease (MRD) monitoring. KITCHENER, ON, ...

Researchers have developed a human intestinal cell model that closely mimics the structure and function of the human gut, enabling more precise prediction of drug-induced gastrointestinal toxicity ...

Rhythm Biosciences is entering a new commercial era, following the first sale of its revolutionary Colostat bowel cancer assay. ... Read More The post Health Check: Rhythm Biosciences is in the groove ...

Dr. William Chen discusses NAMs, AI, and the future of risk assessment for cell-based foods With cultivated meat emerging as one of the most promising innovations in alternative proteins, regulators ...